Page last updated: 2024-11-02

pargyline and Syncope

pargyline has been researched along with Syncope in 3 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MOSER, M1
BRODOFF, B1
MILLER, A1
GOLDMAN, AG1
KOHN, RM1
BEASLEY, EW1

Other Studies

3 other studies available for pargyline and Syncope

ArticleYear
PARGYLINE TREATMENT OF HYPERTENSION. EXPERIENCE WITH A NONHYDRAZINE AMINE OXIDASE INHIBITOR.
    JAMA, 1964, Jan-18, Volume: 187

    Topics: Antihypertensive Agents; Diuretics; Erectile Dysfunction; Geriatrics; Humans; Hypertension; Hypotens

1964
NOCTURNAL ORTHOSTATIC SYNCOPE IN PARGYLINE THERAPY.
    JAMA, 1964, Jan-18, Volume: 187

    Topics: Antihypertensive Agents; Erectile Dysfunction; Humans; Hypotension; Hypotension, Orthostatic; Male;

1964
HYPERTENSIVE REACTION TO PARGYLINE AND CHEESE.
    Lancet (London, England), 1964, Sep-12, Volume: 2, Issue:7359

    Topics: Antihypertensive Agents; Cheese; Geriatrics; Headache; Hypertension; Juvenile Delinquency; Monoamine

1964